2022;23 doi: 10.3390/ijms232012671
Exposure to 3.3 mg/m 3 produced no effects
Studies have commenced to explore the potential of employing natural compounds as therapeutic interventions for TBI
R., & Matczuk, M
Reduced glutathione or GSH serves as the cornerstone for maintaining: Cellular redox homeostasis [1] Neutralizing free radicals [1] Heavy-metal detoxification [1] Regulate pigmentation pathways [1] The Bioavailability Paradox Despite its unmatched therapeutic potential, standard oral glutathione suffers from significant biological limitations
Diabetes Mellitus (E08E13) E10.9 Type 1 diabetes mellitus without complications E11.9 Type 2 diabetes mellitus without complications E11.65 Type 2 diabetes mellitus with hyperglycemia E11.21 Type 2 diabetes mellitus with diabetic nephropathy E11.22 Type 2 diabetes mellitus with diabetic chronic kidney disease E11.40 Type 2 diabetes mellitus with diabetic neuropathy, unspecified E11.51 Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene E11.69 Type 2 diabetes mellitus with other specified complication E13.9 Other specified diabetes mellitus without complications Thyroid Disorders (E00E07) E03.9 Hypothyroidism, unspecified E03.8 Other specified hypothyroidism E05.00 Thyrotoxicosis with diffuse goiter without thyrotoxic crisis or storm E05.10 Thyrotoxicosis with toxic single thyroid nodule without thyrotoxic crisis or storm E06.3 Autoimmune thyroiditis E07.9 Disorder of thyroid, unspecified Disorders of Other Endocrine Glands (E20E35) E20.9 Hypoparathyroidism, unspecified E21.0 Primary hyperparathyroidism E22.0 Acromegaly and pituitary gigantism E23.0 Hypopituitarism E24.0 Pituitary-dependent Cushings disease E27.1 Primary adrenocortical insufficiency E27.2 Addisonian crisis E34.0 Carcinoid syndrome E34.9 Endocrine disorder, unspecified Lipid Metabolism Disorders (E78) E78.0 Pure hypercholesterolemia E78.1 Pure hyperglyceridemia E78.2 Mixed hyperlipidemia E78.5 Hyperlipidemia, unspecified Obesity and Other Hyperalimentation (E66) E66.9 Obesity, unspecified E66.01 Morbid (severe) obesity due to excess calories E66.8 Other obesity Nutritional Deficiencies (E50E64) E55.9 Vitamin D deficiency, unspecified E53.8 Deficiency of other specified B group vitamins E64.9 Sequelae of unspecified nutritional deficiency Electrolyte and Fluid Balance Disorders (E87) E87.1 Hypo-osmolality and hyponatremia E87.2 Acidosis E87.3 Alkalosis E87.5 Hyperkalemia E87.6 Hypokalemia E87.8 Other disorders of electrolyte and fluid balance, not elsewhere classified Other Endocrine Disorders E16.1 Other hypoglycemia E16.2 Hypoglycemia, unspecified E23.2 Diabetes insipidus E24.8 Other Cushings syndrome E26.0 Primary hyperaldosteronism E27.3 Drug-induced adrenocortical insufficiency E31.9 Polyglandular dysfunction, unspecified For more information on how DocVilla can support your practice, visit our website or contact our support team
